探讨肠易激综合征临床特征与临床疗效观察.docVIP

精品论文 参考文献 探讨肠易激综合征临床特征与临床疗效观察 东宁市中医院 157299 【摘 要】目的：探讨并分析肠易激综合征的临床特征。方法：此次研究的对象是选取2011年6月-2015年1月入住笔者所在医院消化内科的肠易激综合征患者260例，将其临床资料进行回顾性分析，并按双盲法随机分组，对照组130例患者患者应用培菲康治疗，试验组130例患者在对照组治疗的基础上应用痛泻宁颗粒治疗，比较两组治疗效果。结果：试验组症状程度评分为（0.52plusmn;0.02）分，症状频率评分为（0.95plusmn;0.06）分，均优于对照组的（2.95plusmn;0.56）分、（2.85plusmn;0.36）分，组间比较差异均有统计学意义（Plt;0.05）；试验组肠易激综合征治疗总有效率为96.2%，高于对照组的84.6%，两组比较差异有统计学意义（Plt;0.05）。结论：肠易激综合征患者多表现为腹痛、排便习惯改变、黏液便，该病具有反复发作、持续存在的临床特征，痛泻宁颗粒联合培菲康治疗肠易激综合征，收效满意，值得在临床应用推广。 【关键词】肠易激综合征；临床特征；治疗效果 Abstract：Objective：To explore and analyze the clinical characteristics of irritable bowel syndrome.Methods：the object of the study is selected June 2011 and 2015 1 month stay where the author Hospital Department of Gastroenterology；intestinal irritable bowel syndrome 260 cases of patients，the clinical data were retrospectively analyzed，and according to double-blind randomization method，the control group（130 cases of patients were treated with Bifico treatment.The experimental group 130 patients in the control treatment group based on the application of Tongxiening granule in treating，compared two groups of treatment effect.Results：experimental group，the degree of symptom score for（0.52 + 0.02），frequency of symptom score for（0.95 + 0.06），were better than those of the control group（2.95 + 0.56），（2.85 + 0.36），between group differences were statistically significant（P lt; 0.05）；test group irritable bowel syndrome treatment total effective rate was 96.2%，higher than the control group of 84.6%，the difference between the two groups has statistical significance（P lt; 0.05）.Conclusion：irritable bowel syndrome patients with multiple manifestations were abdominal pain，bowel habit change，mucous stool，the disease with clinical features of recurrent，persistent and painful diarrhea granule combined with Bifico in treatment of irritable bowel syndrome，satisfied with the results，it is worth in clinical application. Irritable bowel syndrome；clinical characteristics；therapeutic effect 肠易激综合